Article

Interview: The critical role of digital engagement in connecting HCDMs and payers

Celebrating Milestone Pharmaceuticals, our “Emerging biopharma category” AMCP Innovation and Impact awards winner.
*Available in English only
*Available in English only
At AMCP 2025 in Houston, Milestone Pharmaceuticals stood out with its impactful digital engagement strategies, earning the Innovation and Impact Award in the mid-to-large biopharma category. John Jackimiec, Vice President of Market Access, examines the dynamics of digital transformation and its role in the company’s success.

In the interview, John Jackimiec shared valuable insights into the critical role digital engagement plays in connecting with healthcare decision-makers and payers. He also discussed the shifting landscape of virtual communications in the wake of COVID-19 and its broader implications for the biopharma industry. Listen to the interview to gain a deeper understanding of Milestone Pharmaceuticals' approach to digital strategies and how these efforts help overcome challenges while maintaining momentum in a rapidly evolving industry.
*Available in English only

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.

Related resources

Webinar

Navigating global policy shifts: Implications for Europe's pharma landscape

Webinar

Unlocking Access: Navigating Pharma’s Regulatory Crossroads

Report

Unlock the future of market access in 2026: Cencora’s essential guide to navigating a shifting healthcare landscape